| 499 |
18: Activation, AhR |
216: Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 501 |
54: Up Regulation, CD36 |
465: Increased, FA Influx |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|
| 503 |
216: Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway) |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 504 |
465: Increased, FA Influx |
291: Accumulation, Triglyceride |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 505 |
465: Increased, FA Influx |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|
| 506 |
18: Activation, AhR |
466: Up Regulation, LDLR (low density lipoprotein receptor) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 507 |
466: Up Regulation, LDLR (low density lipoprotein receptor) |
467: Increased, LDL uptake |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 508 |
467: Increased, LDL uptake |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 509 |
18: Activation, AhR |
450: Decrease, VLDL export capacity |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 510 |
167: Activation, LXR |
468: Inhibition, PPAR alpha |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 511 |
468: Inhibition, PPAR alpha |
451: Inhibition, Mitochondrial fatty acid beta-oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 512 |
458: Increased, De Novo FA synthesis |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 514 |
327: Accumulation, Fatty acid |
454: Increased, Triglyceride formation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 515 |
327: Accumulation, Fatty acid |
459: Increase, Liver steatosis |
Nov 29, 2016 |
Dec 3, 2016 |
4 AOPs
|
| 516 |
167: Activation, LXR |
470: Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 517 |
470: Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1) |
458: Increased, De Novo FA synthesis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 518 |
245: Activation, PXR/SXR |
471: Inhibition, FoxA2 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 519 |
471: Inhibition, FoxA2 |
472: Down Regulation, CPT1A |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 520 |
472: Down Regulation, CPT1A |
179: Decrease, Fatty acid β-oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 523 |
471: Inhibition, FoxA2 |
474: Down Regulation, HMGCS2 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 524 |
474: Down Regulation, HMGCS2 |
477: Decreased, Ketogenesis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 526 |
245: Activation, PXR/SXR |
462: Up Regulation, SCD-1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 529 |
245: Activation, PXR/SXR |
54: Up Regulation, CD36 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 532 |
478: Activation, NRF2 |
479: Activation, NR1H4 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 533 |
479: Activation, NR1H4 |
480: Activation, SHP |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|